MedPath

Everest Medicines II (HK) Limited

πŸ‡­πŸ‡°Hong Kong, China
Ownership
-
Established
2018-12-24
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

PPB:3

Drug Approvals

VELSIPITY TABLETS 2MG

Approval Date
Apr 25, 2025
PPB

NEFECON MODIFIED-RELEASE CAPSULES 4MG

Approval Date
Apr 29, 2024
PPB

XERAVA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG

Approval Date
Sep 27, 2022
PPB

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.